Intrexon secures $100 million in Series E financing - MarketLine Financial Deals

Intrexon secures $100 million in Series E financing

Intrexon secures $100 million in Series E financing - MarketLine Financial Deals
Intrexon secures $100 million in Series E financing
Published May 31, 2011
2 pages — Published May 31, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Intrexon Corporation, a US-based life sciences company focused on the research and development of biotherapeutic control systems, has closed a $100 million Series E round of financing.

  
Source:
Document ID
MA64922_110602
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Intrexon secures $100 million in Series E financing" May 31, 2011. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Intrexon-secures-100-million-in-Series-E-financing-2052-61802>
  
APA:
MarketLine Financial Deals. (2011). Intrexon secures $100 million in Series E financing May 31, 2011. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Intrexon-secures-100-million-in-Series-E-financing-2052-61802>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.